Thalidomide-O-PEG2-Propargyl CAS:2098487-52-4 is a type of small molecule drug that is used in the treatment of certain types of cancer and inflammatory diseases. It is composed of several functional groups, including a thalidomide group, a polyethylene glycol (PEG) spacer, and a propargyl group.
Thalidomide is a type of immunomodulatory drug that has been shown to be effective in treating certain types of cancer, such as multiple myeloma and myelodysplastic syndromes, as well as inflammatory diseases such as rheumatoid arthritis and Crohn’s disease. The PEG spacer in Thalidomide-O-PEG2-Propargyl is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The propargyl group is an important chemical moiety that can be used for bioconjugation purposes.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
